SHORT MINI-FUTURE - STRYKER CORP. Share Price

Certificat

DE000VM55DS6

Delayed Deutsche Boerse AG 15:45:06 09/05/2024 BST
11 EUR -3.08% Intraday chart for SHORT MINI-FUTURE - STRYKER CORP.
Current month+7.18%
1 month+23.91%
Date Price Change Volume
09/05/24 11 -3.08% 0
08/05/24 11.35 +2.62% 0
07/05/24 11.06 -4.82% 0
06/05/24 11.62 +2.92% 0
03/05/24 11.29 -2.34% 0

Delayed Quote Deutsche Boerse AG

Last update May 09, 2024 at 03:45 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying STRYKER CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM55DS
ISINDE000VM55DS6
Date issued 29/11/2023
Strike 450.2 $
Maturity Unlimited
Parity 10 : 1
Emission price 14.85
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 15.06
Lowest since issue 8.26
Spread 0.04
Spread %0.36%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
329.3 USD
Average target price
372.4 USD
Spread / Average Target
+13.08%
Consensus